INTERLEUKIN INHIBITORS
- anakinra (KINERET)
- basiliximab (SIMULECT)
- bimekizumab (BIMZELX)
- brodalumab (SILIQ)
- canakinumab (ILARIS)
- guselkumab (TREMFYA, TREMFYA I.V., TREMFYA ONE-PRESS)
- ixekizumab (TALTZ)
- mirikizumab (OMVOH)
- risankizumab (SKYRIZI)
- sarilumab (KEVZARA)
- satralizumab (ENSPRYNG)
- secukinumab (COSENTYX)
- siltuximab (SYLVANT)
- spesolimab (SPEVIGO)
- tildrakizumab (ILUMYA)
- tocilizumab (TYENNE, ACTEMRA)
- ustekinumab (OTULFI, JAMTEKI, STEQEYMA IV, FINLIUS I.V., STEQEYMA, STELARA, FINLIUS, STELARA I.V., WEZLANA I.V., OTULFI I.V., WEZLANA)
Using Health Canada Drug Database
updated on 14Sep2025.